The present disclosure provides advantageous graphene/graphite stabilized composites (e.g., graphene/graphite stabilized emulsion-templated foam composites), and improved methods for fabricating such graphene/graphite stabilized composites. More particularly, the present disclosure provides improved methods for fabricating pristine, graphene/graphite/polymer composite foams derived from emulsions stabilized by graphene/graphite kinetic trapping. In exemplary embodiments, the present disclosure provides that, instead of viewing the insolubility of pristine graphene/graphite as an obstacle to be overcome, it is utilized as a means to create or fabricate water/oil emulsions, with graphene/graphite stabilizing the spheres formed. These emulsions are then the frameworks used to make foam composites that have shown bulk conductivities up to about 2 S/m, as well as compressive moduli up to about 100 MPa and breaking strengths of over 1200 psi, with densities as low as about 0.25 g/cm.sup.3.

Provided herein is a cesium adsorbent including: a support modified to have a carboxyl group on a surface thereof; and Prussian blue synthesized on the surface of the modified support, wherein the Prussian blue is at least partially chemically bound with the surface of the support. The cesium adsorbent may effectively adsorb cesium, which is a radioactive element released into the water and may be easily prepared using a simple solution process.

Methods of disposing of pharmaceuticals including liquid pharmaceuticals and dissolved solid pharmaceuticals are disclosed. The methods relate to depositing one or more liquid pharmaceuticals into or onto a substrate that includes (a)(i) fibers, or (ii) both fibers and foam, and (b) activated carbon. The substrate adsorbs active pharmaceutical ingredients and absorbs a carrier liquid to facilitate safe disposal of the one or more liquid pharmaceuticals. Pharmaceutical disposal kits suitable for disposing of liquid pharmaceuticals and dissolved solid pharmaceuticals are also disclosed. The pharmaceutical disposal kits include a substrate that (1) includes (a)(i) fibers or (ii) both fibers and foam, and (b) activated carbon, and (2) is capable of adsorbing active pharmaceutical ingredients and absorbing a carrier liquid to facilitate safe disposal of the one or more liquid pharmaceuticals.

The present invention is based on the use of surface adsorption to capture CO.sub.2 molecules from air, without requiring the need for bulk absorption within the bulk of the sorbent. Since surface adsorption is a much faster process than bulk absorption, the present invention offers a greatly increased CO.sub.2 capture rate, as well as a greatly improved energy efficiency, over conventional systems. The invention involves the use of a molecular monolayer of CO.sub.2 sorbent, a process and a system for capturing CO.sub.2 from air employing such a molecular monolayer of CO.sub.2 sorbent.

A composite material of polyurethane foam having a layer of reduced graphene oxide and polystyrene is described. This composite material may be made by contacting a polyurethane foam with a suspension of reduced graphene oxide, drying, and then irradiating in the presence of styrene vapor. The composite material has a hydrophobic surface that may be exploited for separating a nonpolar phase, such as oil, from an aqueous solution.

A method and exhaust gas treatment system for treating an ammonia-containing exhaust gas, for example a livestock house exhaust gas. The exhaust gas treatment system comprises a plurality of sorbent beds comprising a copper-doped small-pore zeolite, a valve system configured to establish independently for each sorbent bed fluid communication in a first or second configuration, wherein in the first configuration a flow of ammonia-containing exhaust gas contacts the sorbent bed at a temperature of less than 50° C. for storing the ammonia; and in the second configuration a flow of heated gas maintains the sorbent bed at a temperature of at least 300° C. for releasing and treating the ammonia in situ.

An evaporative emission control canister system comprises an initial adsorbent volume having an effective incremental adsorption capacity at 25° C. of greater than 35 grams n-butane/L between vapor concentration of 5 vol % and 50 vol % n-butane, and at least one subsequent adsorbent volume having an effective incremental adsorption capacity at 25° C. of less than 35 grams n-butane/L between vapor concentration of 5 vol % and 50 vol % n-butane, an effective butane working capacity (BWC) of less than 3 g/dL, and a g-total BWC of between 2 grams and 6 grams. The evaporative emission control canister system has a two-day diurnal breathing loss (DBL) emissions of no more than 20 mg at no more than 210 liters of purge applied after the 40 g/hr butane loading step.

An absorbent belt according to an embodiment is for absorbing an oil contained in a cleaning liquid, and the absorbent belt includes a sponge member coated with dopamine (DA) formed by immersing a sponge in a solution mixed with the dopamine in a preset range of 1 g/L or more and 16 g/L or less.

This invention relates to a Cu-BTC MOF which is water stable. The Cu-BTC MOF has been modified by substituting some of the BTC ligand (1,3,5, benzene tricarboxylic acid) with 5-aminoisophthalic acid (AIA). The resultant MOF retains at least 40% of its as synthesized surface area after exposure to liquid water at 60° C. for 6 hours. This is an unexpected result versus the MOF containing only the BTC ligand. This MOF can be used to abate contaminants such as ammonia in gas streams and especially air streams.

A dissolved air floatation apparatus including an ultrafine bubble-containing liquid production device and a dissolved air floatation tank. The ultrafine bubble-containing liquid production device includes a gas-liquid mixing unit and a bubble-containing liquid separation device. The bubble-containing liquid separation device swirls a liquid containing ultrafine bubbles and larger bubbles in a storage tank to concentrate the liquid that contains the ultrafine bubbles and the liquid that contains the larger bubbles to a central part of the swirling flow followed by discharge. A pressurized ultrafine bubble-containing liquid is mixed in a raw liquid containing a subject to be cleansed and is poured into the dissolved air floatation tank to cause a suspended substance and a dissolved component in the raw liquid to be adsorbed on an interface of fine bubbles and be floated in the dissolved air floatation tank to be extracted.